Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

cancer

  • You have access
    Repetitive early FAPI-PET acquisition comparing FAPI-02, FAPI-46 and FAPI-74: methodological and diagnostic implications for malignant, inflammatory and degenerative lesions
    Frederik M. Glatting, Jorge Hoppner, Dawn P. Liew, Antonia van Genabith, Anna-Maria Spektor, Levin Steinbach, Alexander Hubert, Clemens Kratochwil, Frederik L. Giesel, Katharina Dendl, Hendrik Rathke, Hans-Ulrich Kauczor, Peter E. Huber, Uwe A. Haberkorn and Manuel Röhrich
    Journal of Nuclear Medicine May 26, 2022, jnumed.122.264069; DOI: https://doi.org/10.2967/jnumed.122.264069
  • You have access
    Signaling Pathways That Drive 18F-FDG Accumulation in Cancer
    Jessica R. Salas and Peter M. Clark
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 659-663; DOI: https://doi.org/10.2967/jnumed.121.262609
  • Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients Undergoing <sup>18</sup>F-FDG PET/CT Studies: Association Between Metabolic and Structural Lung Changes
    Open Access
    Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients Undergoing 18F-FDG PET/CT Studies: Association Between Metabolic and Structural Lung Changes
    Cristina Gamila Wakfie-Corieh, Federico Ferrando-Castagnetto, Alba María Blanes García, Marta García García-Esquinas, Aída Ortega Candil, Cristina Rodríguez Rey, María Nieves Cabrera-Martín, Ana Delgado Cano and José Luis Carreras Delgado
    Journal of Nuclear Medicine February 1, 2022, 63 (2) 274-279; DOI: https://doi.org/10.2967/jnumed.121.261915
  • You have access
    The VISION Forward: Recognition and Implication of PSMA-/FDG+ mCRPC
    Hossein Jadvar
    Journal of Nuclear Medicine December 21, 2021, jnumed.121.263274; DOI: https://doi.org/10.2967/jnumed.121.263274
  • Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade
    Open Access
    Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade
    Quentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, Wout de Mey, Thomas Ertveldt, Cleo Goyvaerts, Geert Raes, Kris Thielemans, Marleen Keyaerts, Nick Devoogdt and Karine Breckpot
    Journal of Nuclear Medicine November 1, 2021, 62 (11) 1638-1644; DOI: https://doi.org/10.2967/jnumed.120.258871
  • You have access
    PET/MRI Improves Management of Children with Cancer
    Lucia Baratto, K. Elizabeth Hawk, Lisa States, Jing Qi, Sergios Gatidis, Louise Kiru and Heike E. Daldrup-Link
    Journal of Nuclear Medicine October 1, 2021, 62 (10) 1334-1340; DOI: https://doi.org/10.2967/jnumed.120.259747
  • 
<sup>89</sup>Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
    You have access
    89Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
    Kyung-Ho Jung, Jin Won Park, Jin Hee Lee, Seung Hwan Moon, Young Seok Cho and Kyung-Han Lee
    Journal of Nuclear Medicine May 10, 2021, 62 (5) 656-664; DOI: https://doi.org/10.2967/jnumed.120.250720
  • You have access
    Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
    Giacomo Pirovano, Sheryl Roberts, Susanne Kossatz and Thomas Reiner
    Journal of Nuclear Medicine October 1, 2020, 61 (10) 1419-1427; DOI: https://doi.org/10.2967/jnumed.119.238279
  • You have access
    Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer
    Lucia Baratto, Heying Duan, Helmut Mäcke and Andrei Iagaru
    Journal of Nuclear Medicine June 1, 2020, 61 (6) 792-798; DOI: https://doi.org/10.2967/jnumed.119.234971
  • You have access
    Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain Injury
    April Alcantara, Gholam R. Berenji, Carole S. Scherling, Beata Durcanova, Daniel Diaz-Aguilar and Daniel H.S. Silverman
    Journal of Nuclear Medicine December 1, 2019, 60 (12) 1682-1690; DOI: https://doi.org/10.2967/jnumed.119.237578

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire